The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response
The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response
复制标题
结缔组织生长因子的C端模块IV是Th17反应的新型免疫调节剂
作者:
R. Rodrigues;Raúl R. Rodrigues;S. Rayego‐Mateos;B. Suarez;Carolina Lavoz;L. Aroeira;E. Sanchez;M. Orejudo;M. Alique;C. López;A. Ortiz;J. Egido;M. Ruíz
Connective tissue growth factor (CTGF/CCN2) is a matricellular protein susceptible to proteolytic degradation. CCN2 levels have been suggested as a potential risk biomarker in several chronic diseases. In body fluids, CCN2 full-length and its degradation fragments can be found; however, their in vivo effects are far from being elucidated. CCN2 was described as a profibrotic mediator, but this concept is changing to a proinflammatory cytokine. In vitro, CCN2 full-length and its C-terminal module IV (CCN2(IV)) exert proinflammatory properties. Emerging evidence suggest that Th17 cells, and its effector cytokine IL-17A, participate in chronic inflammatory diseases. Our aim was to explore whether CCN2(IV) could regulate the Th17 response. In vitro, stimulation of human naive CD4+ T lymphocytes with CCN2(IV) resulted in differentiation to Th17 phenotype. The in vivo effects of CCN2(IV) were studied in C57BL/6 mice. Intraperitoneal administration of recombinant CCN2(IV) did not change serum IL-17A levels, but caused an activation of the Th17 response in the kidney, characterized by interstitial infiltration of Th17 (IL17A+/CD4+) cells and upregulation of proinflammatory mediators. In CCN2(IV)-injected mice, elevated renal levels of Th17-related factors (IL-17A, IL-6, STAT3 and RORγt) were found, whereas Th1/Th2 cytokines or Treg-related factors (TGF-β and Foxp-3) were not modified. Treatment with an anti-IL-17A neutralizing antibody diminished CCN2(IV)-induced renal inflammation. Our findings unveil that the C-terminal module of CCN2 induces the Th17 differentiation of human Th17 cells and causes a renal Th17 inflammatory response. Furthermore, these data bear out that IL-17A targeting is a promising tool for chronic inflammatory diseases, including renal pathologies.
登录
查看更多内容
影响因子:
19.6
作者:
Dong, Xiangyang;Bachman, Lori A.;Miller, Melinda N.;Nath, Karl A.;Griffin, Matthew D.
通讯作者:
Griffin, Matthew D.
DOI:
10.1073/pnas.94.24.12981
发表时间:
1997-11-25
影响因子:
11.1
作者:
Kim, HS;Nagalla, SR;Rosenfeld, RG
通讯作者:
Rosenfeld, RG
DOI:
10.1053/j.ajkd.2010.11.022
发表时间:
2011-06
期刊:
American journal of kidney diseases : the official journal of the National Kidney Foundation
影响因子:
--
作者:
O'Seaghdha CM;Hwang SJ;Bhavsar NA;Köttgen A;Coresh J;Astor BC;Fox CS
通讯作者:
Fox CS
影响因子:
2.8
作者:
Booth AJ;Bishop DK
通讯作者:
Bishop DK
影响因子:
15.9
作者:
Li, Li;Huang, Liping;Okusa, Mark D.
通讯作者:
Okusa, Mark D.